---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-206315"
form_type: "8-K"
ticker: "DBVT"
cik: "0001613780"
company_name: "DBV Technologies S.A."
filed_at: "2026-05-05T23:59:59+00:00"
generated_at: "2026-05-14T23:23:39.417681+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# DBV Technologies grants CEO 1.74M PSUs tied to FDA acceptance of Viaskin Peanut BLAs

## Summary
- 1,740,000 PSUs granted to CEO Daniel Tassé with grant date May 5, 2026.
- 50% vests upon FDA acceptance of BLA for ages 4-7; 50% for ages 1-3.
- Vesting requires continued employment through July 1, 2028; shares delivered in four installments through Jan 2030.
- If FDA accepts single BLA covering both age groups, all PSUs eligible to vest.
- Unvested PSUs cancelled if milestones not achieved by July 1, 2028.

## SEC filing metadata
- accession: 0001193125-26-206315
- form_type: 8-K
- ticker: DBVT
- cik: 0001613780
- company_name: DBV Technologies S.A.
- filed_at: 2026-05-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1613780/000119312526206315/0001193125-26-206315-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1613780/000119312526206315/d150727d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-206315
- JSON: https://secwatch.observer/filing/0001193125-26-206315.json
- Plain text: https://secwatch.observer/filing/0001193125-26-206315.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.